| 1 |
35318116 | PI3K inhibitor impairs tumor progression and enhances sensitivity to anlotinib in anlotinib-resistant osteosarcoma. | 2022 Jun 28 |
1 |
| 2 |
34373220 | Suppressed mitochondrial respiration via NOX5-mediated redox imbalance contributes to the antitumor activity of anlotinib in oral squamous cell carcinoma. | 2021 Jul 20 |
1 |
| 3 |
34421608 | Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways. | 2021 |
2 |
| 4 |
32839434 | Transcriptome profiling analysis reveals that ATP6V0E2 is involved in the lysosomal activation by anlotinib. | 2020 Aug 24 |
3 |